Mettler Toledo

MTD · Health Care · Market cap $27.8B

Q1 FY26 Mar 31, 2026 reported May 8, 2026

Revenue$0.9B +7% year over year

Gross profit$0.6B

Operating profit$0.2B

Net profit$0.2B 18% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.9	100%	+7%
Laboratory Related	0.5	56%	+5%
Industrial Related	0.4	44%	+10%
Cost of revenue	−0.4	44%
Gross profit	0.6	59% margin	−1pp
Research & development	−0.1	5%	+0pp
SG&A	−0.2	27%	+0pp
Operating profit	0.2	26% margin	+0pp
Net profit	0.2	18%	−1pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1	100%	+8%
Laboratory	0.6	60%	+6%
Industrial	0.4	40%	+11%
Retail	0.1	10%	+8%
Cost of revenue	−0.4	40%
Gross profit	0.6	59% margin	−1pp
Research & development	−0.1	5%	+0pp
SG&A	−0.2	24%	+0pp
Operating profit	0.3	30% margin	+0pp
Tax	−0.1
Net profit	0.2	21%	−1pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Mar 31, 2026	May 8, 2026	$0.9B	+7%	22%	$0.2B	18%
Q3 FY25	Jul 1 – Sep 30, 2025	Nov 7, 2025	$1B	+8%	30%	$0.2B	21%